The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be (link sends e-mail)
Study Name on ClinicalTrials.gov (link is external) | Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation |
---|---|
Study Drug | Ivacaftor (VX-770) |
Type of Study Drug | CFTR Modulation |
Study Title | A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation |
Study Phase | 3 |
Study Sponsor | Vertex |
http://clinicaltrials.gov/ct2/show/NCT01946412 (link is external) | |
Participating ECFS-CTN sites | UK: London |
Age | 2 Years and older |